| Date | Title | Description |
| 09.09.2025 | Penn State Researchers Explore 3D Bioprinting to Restore Blood Flow in Reconstructive Surgery | Restoring blood flow to damaged tissue is a major challenge in reconstructive surgery. Researchers at Penn State are testing a combination of 3D bioprinting and a surgical technique called micropuncture to address this problem, supported by... |
| 19.06.2025 | Bridging the Gap: Innovations in Organ Bioprinting and Social Connection | In a world where technology often feels cold and distant, two groundbreaking initiatives are emerging to tackle pressing human needs: the quest for functional organs through bioprinting and the fight against loneliness through social innova... |
| 18.06.2025 | Stanford Develops 3D Printing Algorithm to Advance Vascular Design for Organ Bioprinting | Stanford researchers have taken a major step toward addressing one of the biggest hurdles in organ bioprinting: building realistic vascular networks capable of sustaining lab-grown tissue. Their new platform, published June 12 in Science, a... |
| 13.12.2023 | Stratasys and Siemens Healthineers transform CT imaging technology | 3D printer manufacturer Stratasys has partnered with Siemens Healthineers to conduct a research project focused on advancing medical imaging phantoms used in computed tomography (CT) imaging proving to be a vital tool in hospitals globally.... |
| 05.04.2023 | Stratasys and CollPlant joint development addresses $2.6B bioprinting market opportunity | Stratasys and CollPlant have announced plans to “transform healthcare with industrial scale bioprinting of tissues and organs.” To establish a method for bio-fabricating human tissues and organs utilizing CollPlant Biotechnologies’ rh-Colla... |
| 23.02.2023 | Regenerative Medicine strategy and tissue bioprinting plans announced by 3D Systems | 3D Systems, a leading U.S. additive manufacturing company, has announced plans for a Regenerative Tissue Program (RPT). The strategic initiative aims to develop and commercialize bioprinted human tissue, building upon 3D Systems expertise i... |
| 05.01.2023 | Advancing IVF with 3D printing: a novel approach by UpNano and Fertilis | High-resolution micro-scale 3D printing company UpNano GmbH has announced the development of UpFlow, a photopolymerizing material.
This material enables rapid and precise 3D printing of micro-environments for a new type of dynamic cell cult... |
| 05.01.2023 | CollPlant’s 3D bioprinted breast implants achieve “promising results” in animal testing | Regenerative medicine specialist CollPlant has announced that its proprietary 3D bioprinted breast implants have successfully passed animal testing.
Bioprinted from ‘rhCollagen,’ a plant-based alternative to human collagen, CollPlant’s impl... |
| 15.12.2022 | CollPlant expands 3D bioprinting offering with new collagen-based Collink.3D 90 bio-ink | The votes for our annual awards ceremony are now in! Watch the 2022 3D Printing Industry Awards replay to find out this year’s winners.
3D bioprinting specialist CollPlant has added a new bio-ink to its material portfolio.
Known as ‘Collink... |
| 31.03.2022 | CollPlant to trial 3D bioprinted breast implants in breakthrough animal study | Regenerative medicine specialist CollPlant (NASDAQ: CLGN) has revealed that the 3D bioprinted breast tissues it’s developing are set to enter animal trials in the very near future.
Alongside the release of its FY 2021 results, which show th... |
| 23.02.2022 | CollPlant partners with CELLINK in bid to address $2.8BN regenerative breast implant market | Regenerative medicine specialist CollPlant has partnered with BICO firm CELLINK in an effort to ramp up its production of 3D bioprinted breast implants.
Currently undergoing preclinical trials, CollPlant’s bioprinted grafts are designed to ... |
| 16.02.2022 | CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologies. | CELLINK and CollPlant Enter a Collaboration Agreement to Explore Future Large-Scale Production of CollPlant's Regenerative Breast Implants using CELLINK's Bioprinting technologies.
Wed, Feb 16, 2022 14:00 CET Report this content
CollPlant a... |
| 09.02.2022 | Trestle Biotherapeutics licenses kidney implant 3D bioprinting technology from Harvard | 3D Printing Industry is currently seeking feedback on material usage across the sector. Have your say in the Spotlight on Resin 3D Printing Survey now.
San Diego-based bioengineering start-up Trestle Biotherapeutics has gained a license for... |
| 20.01.2022 | Healshape to raise $6.8M to advance its breast implant 3D bioprinting technology | Insiders and analysts predict the 3D printing trends to watch in our latest series of articles focused on the future of 3D printing.
Healshape, a Lyon, France-based regenerative medicine startup, is expecting to raise $6.8 million in Series... |
| 02.12.2021 | CollPlant Biotechnologies : Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal - Form 6-K | CollPlant Announces Publication Highlighting its rhCollagen-based Photocurable Dermal Filler in the Plastic and Reconstructive Surgery Journal
Preclinical modeling demonstrates potential for filler to enhance cell proliferation and new tiss... |
| 30.11.2021 | CTIBIOTECH develops novel 3D bioprinting platform to treat colon cancer | Regenerative medicine firm CTIBIOTECH has developed a new 3D bioprinting platform to deliver personalized medicine for patients with colorectal cancer.
Developed in partnership with the Medical University of Plovdiv and the UMHAT-Eurohospit... |
| 18.11.2021 | CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results | REHOVOT, Israel, Nov. 18, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today an... |
| 18.11.2021 | CollPlant Biotechnologies Provides Business Updates and Third Quarter 2021 Financial Results | REHOVOT, Israel, Nov. 18, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today an... |
| 18.11.2021 | CollPlant Biotechnologies : Company launches rhCollagen-based BioInk platform with Collink.3DTM for use in 3D bioprinting of human tissues, scaffolds and organs - Form 6-K | Company launches rhCollagen-based BioInk platform with Collink.3DTM for use in 3D bioprinting of human tissues, scaffolds and organs
Rehovot, Israel November 18, 2021 -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic... |
| 15.11.2021 | CollPlant Biotechnologies : Announces Commercial Launch of BioInk Platform with Collink.3DTM for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs - Form 6-K | CollPlant Announces Commercial Launch of BioInk Platform with Collink.3DTM
for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs
rhCollagen-based BioInk provides biopharma and academia with attractive alternative
to tissue extrac... |
| 15.11.2021 | CollPlant Announces Commercial Launch of BioInk Platform with Collink.3D™ for Use in 3D Bioprinting of Human Tissues, Scaffolds and Organs | REHOVOT, Israel, Nov. 15, 2021 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today a... |
| 14.10.2021 | CollPlant : to Present at Dawson James Small Cap Growth Conference on October 21st | REHOVOT, Israel, Oct. 14, 2021 /PRNewswire/ - CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today an... |
| 12.10.2021 | CollPlant Biotechnologies : rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs - Form 6-K | CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs
REHOVOT, Israel, October 11th /PRNewswire/ - CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine... |
| 11.10.2021 | CollPlant :'s rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs | REHOVOT, Israel, Oct. 11, 2021 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today a... |
| 30.09.2021 | CollPlant : to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5, 2021 | REHOVOT, Israel, Sept. 30, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, has be... |
| 27.09.2021 | CollPlant : CEO Yehiel Tal to Discuss Emerging Uses of rhCollagen in Aesthetic and Regenerative Medicine at NANO.IL.2021 Conference | REHOVOT, Israel, Sept. 27, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that M... |
| 09.09.2021 | CollPlant Biotechnologies : CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF) (Form 6-K) | CollPlant CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF)
REHOVOT, Israel, September 9, 2021/PRNewswire/ -- CollPlant (NASDAQ: CLGN),a regenerative and aesthetics medicine company deve... |
| 09.09.2021 | CollPlant : CEO Yehiel Tal elected to the Board of Directors of the International Society for Biofabrication (ISBF) | REHOVOT, Israel, Sept. 9, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that Mr... |
| 07.09.2021 | CollPlant : To Present at the H.C. Wainwright Annual Global Investment Conference in September | REHOVOT, Israel, Sept. 7, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that Mr... |
| 19.08.2021 | CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results | REHOVOT, Israel, Aug. 19, 2021 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced financia... |
| 19.08.2021 | CollPlant Biotechnologies : Provides Business Updates and Second Quarter 2021 Financial Results (Form 6-K) | CollPlant Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results
Co-Develop Agreement with 3D Systems Highlights Expanding Commercial Collaborations
Rehovot, Israel August 19, 2021, CollPlant (Nasdaq: CLGN), a r... |
| 19.08.2021 | CollPlant Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors | REHOVOT, Israel, Aug. 19, 2021 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, announced the appointmen... |
| 19.08.2021 | CollPlant : Biotechnologies Provides Business Updates and Second Quarter 2021 Financial Results | REHOVOT, Israel, Aug. 19, 2021 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced financia... |
| 19.08.2021 | CollPlant : Appoints Medical Aesthetics Veteran Alisa Lask to Board of Directors | REHOVOT, Israel, Aug. 19, 2021 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, announced the appointmen... |
| 16.08.2021 | CollPlant : Biotechnologies to Present on the Use of Collagen BioInk as a Platform for 3D Bioprinting of Tissues and Organs at the Biomaterials For 3D Printing Webinar | REHOVOT, Israel, Aug. 16, 2021 /PRNewswire/ - CollPlant (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing, today announced that Dr. ... |
| 22.06.2021 | CollPlant Biotechnologies : 3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments | High resolution 3D bioprinted soft tissue matrix mimics patient’s anatomy, enables in-growth to facilitate healing and enhanced outcomes
Unlimited supply of plant-based recombinant human collagen (rhCollagen) does not require animal or huma... |
| 22.06.2021 | CollPlant Biotechnologies : 3D Systems and CollPlant Enter into Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments (Form 6-K) | 3D Systems and CollPlant Enter into Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments
● High resolution 3D bioprinted soft tissue matrix mimics patient's anatomy, enables in-growth to fac... |
| 04.06.2021 | COLLPLANT BIOTECHNOLOGIES LTD.
CollPlant Biotechnologies : Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs (Form 6-K) | CollPlant Announces Effectiveness of Uplisting to the Nasdaq Global Market®; Ordinary Shares Replace ADSs
Rehovot, Israel June 4, 2021, CollPlant (NASDAQ:CLGN), a regenerative and aesthetic medicine company, announced today the uplisting of... |
| 27.05.2021 | CollPlant Biotechnologies : Reports First Quarter 2021 Financial Results with Record Revenues of (Form 6-K) | CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of
$14.5 Million
● Operating income for Q1 2021 increased to $10 million
● Strong balance sheet with $49.7 million cash position
Rehovot, Israel May... |
| 27.05.2021 | CollPlant : Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million | REHOVOT, Israel, May 27, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced financial results for the first quarter ended March 31, 2021 and provided an update on the Company's busi... |
| 27.05.2021 | COLLPLANT BIOTECHNOLOGIES LTD.
CollPlant Biotechnologies : Reports First Quarter 2021 Financial Results with Record Revenues of (Form 6-K) | CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of
$14.5 Million
● Operating income for Q1 2021 increased to $10 million
● Strong balance sheet with $49.7 million cash position
Rehovot, Israel May... |
| 27.05.2021 | COLLPLANT HOLDINGS LTD
CollPlant : Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million | REHOVOT, Israel, May 27, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced financial results for the first quarter ended March 31, 2021 and provided an update on the Company's busi... |
| 27.05.2021 | CollPlant Biotechnologies Reports First Quarter 2021 Financial Results with Record Revenues of $14.5 Million | REHOVOT, Israel, May 27, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced financial results for the first quarter ended March 31, 2021 and provided an update on the Company's busi... |
| 25.05.2021 | COLLPLANT BIOTECHNOLOGIES LTD.
CollPlant Biotechnologies : Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs (Form 6-K) | CollPlant Announces Uplisting to the Nasdaq Global Market® and Transition to Trading of Ordinary Shares Instead of ADSs
• Ordinary shares to trade on Nasdaq Global Market effective June 4, 2021
• ADSs to be mandatorily cancelled and exchang... |
| 02.04.2021 | Power Moves: Tradeswell names chief marketing officer; Maryland Tech Council award nominees | Power Moves is a column where we chart the comings and goings of talent across the region. Got a new hire, new gig or promotion? Tell us: baltimore@technical.ly.
Julie Bernard is the new chief marketing officer at Tradeswell, a startup that... |
| 29.03.2021 | COLLPLANT HOLDINGS LTD
CollPlant : Appoints Additive Manufacturing Executive, Hugh Evans to Its Board of Directors | REHOVOT, Israel, March 29, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced the appointment of Hugh Evans to its Board of Directors, increasing the board to six independent membe... |
| 26.03.2021 | CollPlant Biotechnologies Reports Year End Financial Results for Fiscal Year 2020 | REHOVOT, Israel, March 26, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced financial results for the full year ended December 31, 2020 and provided an update on the Company's bus... |
| 26.03.2021 | CollPlant : Biotechnologies Reports Year End Financial Results for Fiscal Year 2020 | REHOVOT, Israel, March 26, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced financial results for the full year ended December 31, 2020 and provided an update on the Company's bus... |
| 26.03.2021 | COLLPLANT HOLDINGS LTD
CollPlant : Biotechnologies Reports Year End Financial Results for Fiscal Year 2020 | REHOVOT, Israel, March 26, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetic medicine company, today announced financial results for the full year ended December 31, 2020 and provided an update on the Company's bus... |
| 04.03.2021 | CollPlant To Present at the H.C. Wainwright Global Life Sciences Conference | REHOVOT, Israel, March 4, 2021 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company, today announced that Mr. Yehiel Tal, Chief Executive Officer of CollPlant, will provide an overview of the company at t... |
| 18.02.2021 | CollPlant Announces Closing of $35.0 Million Registered Direct Offering of American Depositary Shares | REHOVOT, Israel, Feb. 18, 2021 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies (NASDAQ:CLGN), today announced that it has closed the previously announced registered direct offering for the purchase and sale of an aggregate of 2,000,000 of the... |
| 11.02.2021 | CollPlant Announces $35.0 Million Registered Direct Offering of American Depositary Shares | REHOVOT, Israel, Feb. 11, 2021 (GLOBE NEWSWIRE) -- CollPlant Biotechnologies (NASDAQ:CLGN), today announced that it has entered into definitive agreements with several healthcare-focused and other institutional investors for the purchase an... |
| 09.09.2019 | CollPlant Biotechnologies Closes on $5.5 Million Financing | CollPlant (NASDAQ:CLGN), a regenerative medicine company, announced it has closed on a total of $5.5 million in convertible loans. A group of U.S. accredited investors with deep experience in the 3D printing industry purchased $3.5 million ... |
| 10.08.2017 | Israel Agritech Market Map: 400 Startups Putting The Tech in Agritech | For a young nation built on the collectivist agricultural ethos of the Kibbutz movement, it’s perhaps no surprise that Israel’s agricultural technology startup ecosystem is booming.
There are now more than 400 Israel agritech startups worki... |
| 11.05.2017 | New CollPlant division focuses on 3D bioprinting | [Image courtesy of CollPlant]Regenerative medicine company CollPlant said Thursday that it has created a new division to focus on collagen-based bioprinting.
CollPlant has been utilizing its proprietary plant-based rhCollagen technology for... |
| 15.08.2016 | Geltor seeks to disrupt the gelatin market with potentially game-changing animal-free alternative | And while many people don’t have a problem with munching on marshmallows containing fish or pigskin - and manufacturers would argue that gelatin is a sustainable value-added ingredient using parts of the animal we don't generally eat - ther... |